127 related articles for article (PubMed ID: 7192824)
21. Graded response to thymectomy in children with myasthenia gravis.
Tracy MM; McRae W; Millichap JG
J Child Neurol; 2009 Apr; 24(4):454-9. PubMed ID: 19339286
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive treatment for juvenile myasthenia gravis.
Badurska B; Ryniewicz B; Strugalska H
Eur J Pediatr; 1992 Mar; 151(3):215-7. PubMed ID: 1601015
[TBL] [Abstract][Full Text] [Related]
23. Myasthenia gravis: how to treat?
Tireli H; Karlikaya G; Tutkavul K; Akpinar A; Okay T
Acta Myol; 2004 Dec; 23(3):140-5. PubMed ID: 15938570
[TBL] [Abstract][Full Text] [Related]
24. Myasthenia gravis treatment: twelve years experience on 110 patients.
Valli G; Jann S; Premoselli S; Scarlato G
Ital J Neurol Sci; 1987 Dec; 8(6):593-601. PubMed ID: 3429218
[TBL] [Abstract][Full Text] [Related]
25. Transsternal thymectomy for myasthenia gravis: surgical outcome.
Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing outcome of prednisone dose reduction in myasthenia gravis.
Miano MA; Bosley TM; Heiman-Patterson TD; Reed J; Sergott RC; Savino PJ; Schatz NJ
Neurology; 1991 Jun; 41(6):919-21. PubMed ID: 2046940
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis.
Scherpbier HJ; Oosterhuis HJ
Clin Neurol Neurosurg; 1987; 89(3):145-50. PubMed ID: 3665287
[TBL] [Abstract][Full Text] [Related]
28. [Therapy of thymus neoplasms and of myasthenia gravis pseudoparalytica].
Bayer HW; Reismann B
Zentralbl Chir; 1973 Dec; 98(52):1825-34. PubMed ID: 4782941
[No Abstract] [Full Text] [Related]
29. Myasthenia gravis in children: long-term follow-up.
Rodriguez M; Gomez MR; Howard FM; Taylor WF
Ann Neurol; 1983 May; 13(5):504-10. PubMed ID: 6870202
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
[TBL] [Abstract][Full Text] [Related]
31. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
Brunner NG; Berger CL; Namba T; Grob D
Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
[TBL] [Abstract][Full Text] [Related]
32. Prolonged respirator support for the treatment of intractable myasthenia gravis.
Selecky PA; Ziment I
Chest; 1974 Feb; 65(2):207-9. PubMed ID: 4359284
[No Abstract] [Full Text] [Related]
33. [Ocular myasthenia].
Huber A
Klin Monbl Augenheilkd; 1985 Mar; 186(3):158-60. PubMed ID: 3999598
[TBL] [Abstract][Full Text] [Related]
34. [The clinical outcomes of thymectomy combined with radiotherapy or cyclophosphamide treatment for myasthenia gravis patients with thymoma].
Chen Y; Zhang J; Wang W; Wang Z; Dou Y; Wei D
Zhonghua Nei Ke Za Zhi; 2015 Mar; 54(3):201-4. PubMed ID: 26269441
[TBL] [Abstract][Full Text] [Related]
35. Juvenile myasthenia gravis and thymectomy: report of ten cases.
de Assis JL; Marchiori PE; Zambon AA; Scaff M
Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(5):234-6. PubMed ID: 1340608
[TBL] [Abstract][Full Text] [Related]
36. Remission of myasthenia gravis following plasma-exchange.
Pinching AJ; Peters DK
Lancet; 1976 Dec; 2(8000):1373-6. PubMed ID: 63848
[TBL] [Abstract][Full Text] [Related]
37. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
Lin PT; Martin BA; Weinacker AB; So YT
Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645
[TBL] [Abstract][Full Text] [Related]
38. Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.
Durelli L; Maggi G; Casadio C; Ferri R; Rendine S; Bergamini L
J Neurol Neurosurg Psychiatry; 1991 May; 54(5):406-11. PubMed ID: 1865202
[TBL] [Abstract][Full Text] [Related]
39. Myasthenia gravis: prolonged treatment with steroids.
Sghirlanzoni A; Peluchetti D; Mantegazza R; Fiacchino F; Cornelio F
Neurology; 1984 Feb; 34(2):170-4. PubMed ID: 6538004
[TBL] [Abstract][Full Text] [Related]
40. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
Ambrogi V; Mineo TC
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
